Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1977 1
1980 2
1981 1
1983 2
1986 2
1990 1
1995 2
1999 1
2000 1
2001 1
2002 1
2003 2
2004 1
2006 1
2007 7
2008 7
2009 4
2010 6
2011 10
2012 13
2013 2
2014 7
2015 10
2016 4
2017 8
2018 11
2019 11
2020 5
2021 11
2022 9
2023 8
2024 12
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.
Gupta RK, Abdul-Jawad S, McCoy LE, Mok HP, Peppa D, Salgado M, Martinez-Picado J, Nijhuis M, Wensing AMJ, Lee H, Grant P, Nastouli E, Lambert J, Pace M, Salasc F, Monit C, Innes AJ, Muir L, Waters L, Frater J, Lever AML, Edwards SG, Gabriel IH, Olavarria E. Gupta RK, et al. Among authors: gabriel ih. Nature. 2019 Apr;568(7751):244-248. doi: 10.1038/s41586-019-1027-4. Epub 2019 Mar 5. Nature. 2019. PMID: 30836379 Free PMC article.
Enzymes of UDP-GlcNAc biosynthesis in yeast.
Milewski S, Gabriel I, Olchowy J. Milewski S, et al. Among authors: gabriel i. Yeast. 2006 Jan 15;23(1):1-14. doi: 10.1002/yea.1337. Yeast. 2006. PMID: 16408321 Review.
Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study.
Salgado M, Gálvez C, Nijhuis M, Kwon M, Cardozo-Ojeda EF, Badiola J, Gorman MJ, Huyveneers LEP, Urrea V, Bandera A, Jensen BO, Vandekerckhove L, Jurado M, Raj K, Schulze Zur Wiesch J, Bailén R, Eberhard JM, Nabergoj M, Hütter G, Saldaña-Moreno R, Oldford S, Barrett L, Ramirez MLM, Garba S, Gupta RK, Revollo B, Ferra-Coll C, Kuball J, Alter G, Sáez-Cirión A, Diez-Martin JL, Duke ER, Schiffer JT, Wensing A, Martinez-Picado J; IciStem Consortium. Salgado M, et al. Lancet HIV. 2024 Jun;11(6):e389-e405. doi: 10.1016/S2352-3018(24)00090-0. Lancet HIV. 2024. PMID: 38816141 Free PMC article.
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial.
Brittain G, Petrie J, Duffy KEM, Glover R, Hullock K, Papaioannou D, Roldan E, Beecher C, Bursnall M, Ciccarelli O, Coles AJ, Cooper C, Giovannoni G, Gabriel I, Kazmi M, Kyriakou C, Nicholas R, Paling D, Peniket A, Scolding N, Silber E, de Silva T, Venneri A, Walters SJ, Young C, Muraro PA, Sharrack B, Snowden JA; StarMS trial team. Brittain G, et al. Among authors: gabriel i. BMJ Open. 2024 Feb 5;14(2):e083582. doi: 10.1136/bmjopen-2023-083582. BMJ Open. 2024. PMID: 38316583 Free PMC article.
Epidemiological characterization of rare diseases in Brazil: A retrospective study of the Brazilian Rare Diseases Network.
de Oliveira BM, Bernardi FA, Baiochi JF, Neiva MB, Artifon M, Vergara AA, Martins AM, Grumach AS, Acosta AX, Husny ASE, de Freitas Rodrigues Ribeiro B, Ramos CF, Steiner CE, Kim CA, Christofolini DM, Yamada DB, Carvalho EDF, Ribeiro EM, de Arruda Bastos F, Serpa FS, Brandão FR, Adjuto GMAF, Carvalho I, Saute JAM, Junior JCL, Bueno LSM, da Silva LCS, Santos MLSF, Costa MCM, Giusti MMCG, Galera MF, Filho MEC, de Andrade MDFC, De Oliveira Cardoso MT, de Menezes Ferreira MM, Zeny M, Caldato MCF, Sorte NB, Musolino NRC, de Medeiros PFV, Zen PRG, Da Silva RTB, Maia RE, Fock R, Almeida RES, Valle SOR, Amorim T, Teixeira TB, Prazeres VMG, de Faria Ferraz VE, Lima VC, Paiva WJM, Schwartz IVD, Alves D, Félix TM; Raras Network Group. de Oliveira BM, et al. Orphanet J Rare Dis. 2024 Oct 30;19(1):405. doi: 10.1186/s13023-024-03392-7. Orphanet J Rare Dis. 2024. PMID: 39478612 Free PMC article.
Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort Study.
Muraro PA, Zito A, Signori A, Sormani MP, Rigoni E, Pollidoro F, Bergamaschi R, Mariottini A, Malik O, Nandoskar A, Singh-Curry V, Mehra V, Kazmi M, Gabriel I, Silber E, Nicholas R, Scalfari A. Muraro PA, et al. Among authors: gabriel i. Ann Neurol. 2025 Aug;98(2):294-307. doi: 10.1002/ana.27247. Epub 2025 Apr 19. Ann Neurol. 2025. PMID: 40251896 Free PMC article.
Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK.
Muraro PA, Kazmi M, De Matteis E, Brittain G, Mariottini A, Nicholas R, Silber E, Mehra V, Gabriel I, Ciccarelli O, Lee J, Pearce R, Sormani MP, Signori A, Paul R, Malladi R, Potter V, Snowden J, Sharrack B. Muraro PA, et al. Among authors: gabriel i. J Neurol Neurosurg Psychiatry. 2025 Sep 5:jnnp-2025-336755. doi: 10.1136/jnnp-2025-336755. Online ahead of print. J Neurol Neurosurg Psychiatry. 2025. PMID: 40912910
160 results